Astella Blindness News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Astellas Pharma agreed to acquire Iveric Bio for approximately $5.9 billion, in a deal designed to expand the buyer’s eye treatment pipeline.

Glennp sblendorioChris howertonAstellas pharmaIveric bioColleenm kusyNaoki okamuraIveric zimuraAssociation for researchApellis pharmaceuticalsPrescription drug user fee actNew drug applicationLineage cell therapeuticsOphthalmology annual meetingUniversal cellsAstella blindness